| Financial Year |
March 31 2023 |
| Monetary Funds |
3,327,444,281.13 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
355,357,109.35 |
| Accounts Receivable |
3,024,984,426.53 |
| Advances to Suppliers |
114,095,620.10 |
| Other Receivables |
132,371,768.72 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,826,310,646.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
104,369,239.78 |
| Total Current Assets |
8,884,933,091.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
177,709,460.68 |
| Investment Properties |
-- |
| Fixed Assetes |
664,259,691.88 |
| Under-construction Projects |
111,761,969.82 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
279,094,621.34 |
| R&D expenses |
-- |
| Goodwill |
91,648,800.54 |
| Long-Term Deferred and Prepaid Expenses |
30,295,076.30 |
| Deferred Income Tax Assets |
172,970,529.37 |
| Other Non-Current Assets |
66,754,655.54 |
| Sub-Total of Non-Current Assets |
1,668,544,952.53 |
| Total Assets |
10,553,478,044.42 |
| Short-Term Loans |
594,068,131.37 |
| Trading Financial liabilities |
-- |
| Notes Payable |
532,901,113.79 |
| Accounts Payable |
2,244,465,976.98 |
| Accounts Received In Advance |
532,523.63 |
| Employee Compensation Payable |
269,283,194.11 |
| Taxes Payable |
57,163,985.92 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
350,209,924.15 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
15,856,117.90 |
| Other Current Liabilities |
70,492,278.42 |
| Sub-Total of Current Liabilities |
4,261,494,608.44 |
| Long-term Loans |
30,578,140.12 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
32,964,052.53 |
| Deferred Income Tax Liabilities |
1,524,474.18 |
| Other Non-Current Liabilities |
14,780,820.80 |
| Sub-Total of Non-Current Liabilities |
175,928,298.81 |
| Total Liabilities |
4,437,422,907.25 |
| Paid-In Capital(Or Share Stock) |
1,150,216,072.00 |
| Capital Surplus |
1,535,832,425.86 |
| Surplus Reserve |
323,504,115.54 |
| LESS:Treasury Stock |
125,230,622.21 |
| Undistributed Profits |
3,293,536,511.46 |
| Minority Stockholder's Interest |
-22,083,997.78 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,138,139,134.95 |
| Owner's Equity（Stockholder's Equity） |
6,116,055,137.17 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,553,478,044.42 |
